Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis

References

• Jiang X, Ma H, Wang Y, et al. Early life factors and type 2 diabetes mellitus. J Diabetes Res. 2013;2013:485082.
   PubMed Web of Science ®Google Scholar
• Strachan MW, Reynolds RM, Frier BM. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes Metab. 2009;11:407–414.
   PubMed Web of Science ®Google Scholar
• Asfaha S, Padwal R. Antihypertensive drugs and incidence of type 2 diabetes: evidence and implications for clinical practice. Curr Hypertens Rep. 2005;7:314–322.
   PubMed Web of Science ®Google Scholar
• Elnaem MH, Mohamed MHN, Huri HZ, et al. Statin therapy prescribing for patients with type 2 diabetes mellitus: a review of current evidence and challenges. J Pharm Bioallied Sci. 2017;9:80–87.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017;20:9–16.
   PubMed Web of Science ®Google Scholar
• Basat S, Sivritepe R, Ortaboz D, et al. The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus. Aging Male. 2018;21:111–115.
   PubMed Web of Science ®Google Scholar
• Mohamad NV, Wong SK, Wan Hasan WN, et al. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2018;1–12. DOI:10.1080/13685538.2018.1482487
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang Z, Li H, et al. Analysis of cardiovascular risk factors associated with serum testosterone levels according to the US 2011–2012 National Health and Nutrition Examination Survey. Aging Male. 2018;1–8. DOI:10.1080/13685538.2018.1479387
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Kuczerowski R, et al. Hormonal determinants of erectile dysfunction and lower urinary tract symptoms in middle-aged and elderly men with prediabetes. Aging Male. 2015;18:256–264.
   PubMed Web of Science ®Google Scholar
• Khripun I, Vorobyev S, Belousov I, et al. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. Aging Male. 2018;1–9. DOI:10.1080/13685538.2018.1506918
   PubMed Web of Science ®Google Scholar
• Morgunov LY, Denisova IA, Rozhkova TI, et al. Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus. Aging Male. 2018;1–10. DOI:10.1080/13685538.2018.1487932
   PubMed Web of Science ®Google Scholar
• Haider KS, Haider A, Doros G, et al. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a Controlled Registry Study. J Urol. 2018;199:257–265.
   PubMed Web of Science ®Google Scholar
• Groti K, Zuran I, Antonic B, et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018;21:158–169.
   PubMed Web of Science ®Google Scholar
• Saad F, Yassin A, Almehmadi Y, et al. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports. Aging Male. 2015;18:164–168.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Hatami H, Parizadeh D, Bidhendi Yarandi R, et al. Endogenous testosterone does not improve prediction of incident cardiovascular disease in a community-based cohort of adult men: results from the Tehran Lipid and Glucose Study. Aging Male. 2018;1–8. DOI:10.1080/13685538.2018.1466876
   PubMed Web of Science ®Google Scholar
• Livingston M, Kalansooriya A, Hartland AJ, et al. Serum testosterone levels in male hypogonadism: why and when to check – a review. Int J Clin Pract. 2017;71. DOI:10.1111/ijcp.12995
   Web of Science ®Google Scholar
• Lu Y, Li J, Cheng X, et al. Testosterone level in aging male with different glucose tolerance state and its association with osteocalcin. Aging Male. 2018;1–6. DOI:10.1080/13685538.2018.1481940
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–1299.
   PubMed Web of Science ®Google Scholar
• Bai J, Liu Y, Niu GF, et al. Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem Med (Zagreb). 2011;21:65–70.
   PubMed Web of Science ®Google Scholar
• Achemlal L, Tellal S, Rkiouak F, et al. Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005;24:493–496.
   PubMed Web of Science ®Google Scholar
• Corona G, Monami M, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. 2011;34:528–540.
   PubMed Web of Science ®Google Scholar
• Atlantis E, Fahey P, Martin S, et al. Predictive value of serum testosterone for type 2 diabetes risk assessment in men. BMC Endocr Disord. 2016;16:26.
   PubMed Web of Science ®Google Scholar
• Salminen M, Vahlberg T, Raiha I, et al. Sex hormones and the risk of type 2 diabetes mellitus: a 9-year follow up among elderly men in Finland. Geriatr Gerontol Int. 2015;15:559–564.
   PubMed Web of Science ®Google Scholar
• Li JJ, Wittert GA, Vincent A, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metab Clin Exp. 2016;65:883–892.
   PubMed Web of Science ®Google Scholar
• Svartberg J, Schirmer H, Wilsgaard T, et al. Single-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study. Andrology. 2014;2:212–218.
   PubMed Web of Science ®Google Scholar
• Bekaert M, Van Nieuwenhove Y, Calders P, et al. Determinants of testosterone levels in human male obesity. Endocrine. 2015;50:202–211.
   PubMed Web of Science ®Google Scholar
• Daka B, Langer RD, Larsson CA, et al. Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. BMC Endocr Disord. 2015;15:35.
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang A, Yang S, et al. Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes. J Diabetes. 2016;8:508–515.
   PubMed Web of Science ®Google Scholar
• Mattack N, Devi R, Kutum T, et al. The evaluation of serum levels of testosterone in type 2 diabetic men and its relation with lipid profile. J Clin Diagn Res. 2015;9:*BC04–BC07.
   PubMed Web of Science ®Google Scholar
• Rovira-Llopis S, Banuls C, de MAM, et al. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients. Free Radic Biol Med. 2017;108:155–162.
   PubMed Web of Science ®Google Scholar
• Shi MD, Chao JK, Ma MC, et al. The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males. Int J Impot Res. 2014;26:235–240.
   PubMed Web of Science ®Google Scholar
• Xia JW, Tan SJ, Zhang XL, et al. Correlation of serum testosterone with insulin resistance in elderly male type 2 diabetes mellitus patients with osteoporosis. J Diabetes Invest. 2015;6:548–552.
   PubMed Web of Science ®Google Scholar
• Al Hayek AA, Khawaja NM, Khader YS, et al. The prevalence of hypogonadism among diabetic and non-diabetic men in Jordan. J Diabetes Complicat. 2014;28:135–140.
   PubMed Web of Science ®Google Scholar
• Asare-Anane H, Ofori E, Agyemang Y, et al. Obesity and testosterone levels in Ghanaian men with type 2 diabetes. Clin Diabetes. 2014;32:61–65.
   PubMedGoogle Scholar
• Biswas M, Hampton D, Newcombe RG, et al. Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life. Clin Endocrinol (Oxf). 2012;76:665–673.
   PubMed Web of Science ®Google Scholar
• Cao J, Li J, Hao W, et al. Correlation of sex hormone and androgen receptor with diabetes mellitus in elderly men. Aging Male. 2011;14:162–167.
   PubMed Web of Science ®Google Scholar
• Dhindsa S, Miller MG, McWhirter CL, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33:1186–1192.
   PubMed Web of Science ®Google Scholar
• Goto A, Morita A, Goto M, et al. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study. Cardiovasc Diabetol. 2012;11:130.
   PubMed Web of Science ®Google Scholar
• Ho CH, Yu HJ, Wang CY, et al. Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome. PLoS One. 2013;8:e74173.
   PubMed Web of Science ®Google Scholar
• Kim KS, Kang SH, Kim MJ, et al. Low serum testosterone concentrations in hospitalized men with poorly controlled type 2 diabetes. Endocrinol Metab (Seoul). 2014;29:574–578.
   PubMedGoogle Scholar
• Mazur A, Westerman R, Werdecker A, et al. Testosterone and type 2 diabetes in men. Aging Male. 2014;17:18–24.
   PubMed Web of Science ®Google Scholar
• Ng Tang Fui M, Hoermann R, Cheung AS, et al. Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status. Andrology. 2013;1:906–912.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Zgliczyński W, et al. The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population. Biomed Res Int. 2013;2013:767496.
   PubMed Web of Science ®Google Scholar
• Tsilidis KK, Allen NE, Appleby PN, et al. Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2015;136:372–381.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
   PubMed Web of Science ®Google Scholar
• Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64–75.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xiao L, Qin Z, et al. Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis. Oncotarget. 2016;7:67101–67110.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Haider A, Yassin A, Doros G, et al. Effects of long-term testosterone therapy on patients with “diabesity”: results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes. Int J Endocrinol. 2014;2014:683515.
   Web of Science ®Google Scholar
• Haidar A, Yassin A, Saad F, et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007;10:189–196.
   PubMed Web of Science ®Google Scholar
• Li HJ. More attention should be paid to the treatment of male infertility with drugs-testosterone: to use it or not? Asian J Androl. 2014;16:270–273.
   PubMed Web of Science ®Google Scholar
• Hackett G, Cole N, Saghir A, et al. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Andrology. 2017;5:905–913.
   PubMed Web of Science ®Google Scholar
• Panach-Navarrete J, Martinez-Jabaloyas JM. The influence of comorbidities on the aging males’ symptoms scale in patients with erectile dysfunction. Aging Male. 2017;20:146–152.
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male. 2015;18:186–194.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Morgentaler A, et al. Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function Scores. Eur Urol. 2017;72:1000–1011.
   Web of Science ®Google Scholar
• Ahn TY, Park JK, Lee SW, et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med. 2007;4:1269–1276.
   PubMed Web of Science ®Google Scholar
• Neto WK, Gama EF, Rocha LY, et al. Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (Dordr). 2015;37:9742.
   PubMed Web of Science ®Google Scholar